Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The COVID-19 pandemic has had a major impact on patient care(Schmidt et al., 2020). In oncology, it especially challenged the rigorous conduct of clinical trials, notably by delaying site initiation visits, patient enrollment, treatment administration, trial-associated procedures, and data monitoring.
Cancer Cell , résumé, 2020